Literature DB >> 21724437

Alterations in membrane caveolae and BKCa channel activity in skin fibroblasts in Smith-Lemli-Opitz syndrome.

Gongyi Ren1, Robert F Jacob, Yuri Kaulin, Paul Dimuzio, Yi Xie, R Preston Mason, G Stephen Tint, Robert D Steiner, Jean-Baptiste Roullet, Louise Merkens, Diana Whitaker-Menezes, Philippe G Frank, Michael P Lisanti, Robert H Cox, Thomas N Tulenko.   

Abstract

The Smith-Lemli-Opitz syndrome (SLOS) is an inherited disorder of cholesterol synthesis caused by mutations in DHCR7 which encodes the final enzyme in the cholesterol synthesis pathway. The immediate precursor to cholesterol synthesis, 7-dehydrocholesterol (7-DHC) accumulates in the plasma and cells of SLOS patients which has led to the idea that the accumulation of abnormal sterols and/or reduction in cholesterol underlies the phenotypic abnormalities of SLOS. We tested the hypothesis that 7-DHC accumulates in membrane caveolae where it disturbs caveolar bilayer structure-function. Membrane caveolae from skin fibroblasts obtained from SLOS patients were isolated and found to accumulate 7-DHC. In caveolar-like model membranes containing 7-DHC, subtle, but complex alterations in intermolecular packing, lipid order and membrane width were observed. In addition, the BK(Ca) K(+) channel, which co-migrates with caveolin-1 in a membrane fraction enriched with cholesterol, was impaired in SLOS cells as reflected by reduced single channel conductance and a 50 mV rightward shift in the channel activation voltage. In addition, a marked decrease in BK(Ca) protein but not mRNA expression levels was seen suggesting post-translational alterations. Accompanying these changes was a reduction in caveolin-1 protein and mRNA levels, but membrane caveolar structure was not altered. These results are consistent with the hypothesis that 7-DHC accumulation in the caveolar membrane results in defective caveolar signaling. However, additional cellular alterations beyond mere changes associated with abnormal sterols in the membrane likely contribute to the pathogenesis of SLOS.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21724437      PMCID: PMC3365561          DOI: 10.1016/j.ymgme.2011.04.019

Source DB:  PubMed          Journal:  Mol Genet Metab        ISSN: 1096-7192            Impact factor:   4.797


  63 in total

1.  A rapid method of total lipid extraction and purification.

Authors:  E G BLIGH; W J DYER
Journal:  Can J Biochem Physiol       Date:  1959-08

2.  X-RAY DIFFRACTION PATTERN OF NERVE MYELIN: A METHOD FOR DETERMINING THE PHASES.

Authors:  M F MOODY
Journal:  Science       Date:  1963-11-29       Impact factor: 47.728

3.  Maxi-K channels localize to caveolae in human myometrium: a role for an actin-channel-caveolin complex in the regulation of myometrial smooth muscle K+ current.

Authors:  Adam M Brainard; Andrea J Miller; Jeffrey R Martens; Sarah K England
Journal:  Am J Physiol Cell Physiol       Date:  2005-02-09       Impact factor: 4.249

4.  Protein measurement with the Folin phenol reagent.

Authors:  O H LOWRY; N J ROSEBROUGH; A L FARR; R J RANDALL
Journal:  J Biol Chem       Date:  1951-11       Impact factor: 5.157

5.  Idiopathic persistent pulmonary hypertension in an infant with Smith-Lemli-Opitz syndrome.

Authors:  Anup C Katheria; Elizer Masliah; Kurt Benirschke; Ken L Jones; Jae H Kim
Journal:  Fetal Pediatr Pathol       Date:  2010       Impact factor: 0.958

6.  Two sterol regulatory element-like sequences mediate up-regulation of caveolin gene transcription in response to low density lipoprotein free cholesterol.

Authors:  A Bist; P E Fielding; C J Fielding
Journal:  Proc Natl Acad Sci U S A       Date:  1997-09-30       Impact factor: 11.205

7.  Cholesterol targeting alters lipid raft composition and cell survival in prostate cancer cells and xenografts.

Authors:  Liyan Zhuang; Jayoung Kim; Rosalyn M Adam; Keith R Solomon; Michael R Freeman
Journal:  J Clin Invest       Date:  2005-03-17       Impact factor: 14.808

8.  Caveolae targeting and regulation of large conductance Ca(2+)-activated K+ channels in vascular endothelial cells.

Authors:  Xiao-Li Wang; Dan Ye; Timothy E Peterson; Sheng Cao; Vijay H Shah; Zvonimir S Katusic; Gary C Sieck; Hon-Chi Lee
Journal:  J Biol Chem       Date:  2005-01-23       Impact factor: 5.157

9.  Cholesterol and fatty acids regulate dynamic caveolin trafficking through the Golgi complex and between the cell surface and lipid bodies.

Authors:  Albert Pol; Sally Martin; Manuel A Fernández; Mercedes Ingelmo-Torres; Charles Ferguson; Carlos Enrich; Robert G Parton
Journal:  Mol Biol Cell       Date:  2005-02-02       Impact factor: 4.138

Review 10.  3beta-hydroxysterol Delta7-reductase and the Smith-Lemli-Opitz syndrome.

Authors:  Lina S Correa-Cerro; Forbes D Porter
Journal:  Mol Genet Metab       Date:  2004-12-19       Impact factor: 4.797

View more
  8 in total

1.  Desmosterolosis and desmosterol homeostasis in the developing mouse brain.

Authors:  Luke B Allen; Thiago C Genaro-Mattos; Ned A Porter; Károly Mirnics; Zeljka Korade
Journal:  J Inherit Metab Dis       Date:  2019-04-08       Impact factor: 4.982

2.  Mutational spectrum of smith-lemli-opitz syndrome patients in hungary.

Authors:  I Balogh; K Koczok; G P Szabó; O Török; K Hadzsiev; G Csábi; L Balogh; E Dzsudzsák; E Ajzner; L Szabó; V Csákváry; A V Oláh
Journal:  Mol Syndromol       Date:  2012-11-09

3.  7-Dehydrocholesterol (7-DHC), But Not Cholesterol, Causes Suppression of Canonical TGF-β Signaling and Is Likely Involved in the Development of Atherosclerotic Cardiovascular Disease (ASCVD).

Authors:  Shuan Shian Huang; I-Hua Liu; Chun-Lin Chen; Jia-Ming Chang; Frank E Johnson; Jung San Huang
Journal:  J Cell Biochem       Date:  2016-12-13       Impact factor: 4.429

4.  7DHC-induced changes of Kv1.3 operation contributes to modified T cell function in Smith-Lemli-Opitz syndrome.

Authors:  András Balajthy; Sándor Somodi; Zoltán Pethő; Mária Péter; Zoltán Varga; Gabriella P Szabó; György Paragh; László Vígh; György Panyi; Péter Hajdu
Journal:  Pflugers Arch       Date:  2016-06-17       Impact factor: 3.657

5.  Pathogenesis, Epidemiology, Diagnosis and Clinical Aspects of Smith-Lemli-Opitz Syndrome.

Authors:  Simona E Bianconi; Joanna L Cross; Christopher A Wassif; Forbes D Porter
Journal:  Expert Opin Orphan Drugs       Date:  2015-03       Impact factor: 0.694

Review 6.  An association of metabolic syndrome constellation with cellular membrane caveolae.

Authors:  Wei-Zheng Zhang
Journal:  Pathobiol Aging Age Relat Dis       Date:  2014-02-12

7.  Elevated Autophagy and Mitochondrial Dysfunction in the Smith-Lemli-Opitz Syndrome.

Authors:  Shaohua Chang; Gongyi Ren; Robert D Steiner; Louise Merkens; Jean-Baptiste Roullet; Zeljka Korade; Paul J DiMuzio; Thomas N Tulenko
Journal:  Mol Genet Metab Rep       Date:  2014

8.  7-dehydrocholesterol efficiently supports Ret signaling in a mouse model of Smith-Opitz-Lemli syndrome.

Authors:  Myriam Gou-Fàbregas; Anna Macià; Carlos Anerillas; Marta Vaquero; Mariona Jové; Sanjay Jain; Joan Ribera; Mario Encinas
Journal:  Sci Rep       Date:  2016-06-23       Impact factor: 4.379

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.